Osprey Medical
  • DyeVert™
    • DyeVert™ PLUS EZ
    • Instructions for Use – United States Only
  • Be Kind to Kidneys™
  • Patients
    • About Your Kidneys
    • Patients at Risk
    • Kidney Kindness in the Cath Lab
    • Martha’s Story
    • DyeVert™ Plus System
  • International
    • DyeVert™ PLUS EZ
    • DyeVert™ Power XT
    • Instructions for Use – International
    • Instructions for Use – Australia
    • Instructions for Use – Canada
  • About Us
    • Management
    • Board of Directors
    • Patents
    • Contact Us
  • Search
  • Menu Menu

About Us

  • Management
  • Board of Directors
  • News
  • Patents

News

Supplier Horizon Award

Osprey receives Supplier Horizon Award from Premier Inc

September 29, 2020/in News

Osprey Medical (ASX: OSP) is pleased to announce that the Company is a winner of the prestigious Supplier Horizon Award from Premier Inc., one of the leading Group Purchasing Organizations (GPOs) in the US with over 4,100 member hospitals in its network. Osprey was one of nine suppliers this year to receive this prestigious award and was recognized for its support of Premier members through exceptional local customer service and engagement, value creation through clinical excellence and commitment to lower costs.

Read more

https://ospreymed.com/wp-content/uploads/2020/10/Supplier-Horizon-Award.jpg 600 600 Cat Gilfillen https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Cat Gilfillen2020-09-29 01:08:262020-10-01 01:08:51Osprey receives Supplier Horizon Award from Premier Inc
DyeVert Logo

GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)

July 30, 2020/in News

Osprey Medical (ASX: OSP) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVert contrast minimization devices, complemented by GE Healthcare’s range of iodinated x-ray contrast media, offer healthcare professionals a technology platform to address the rising problem of Acute Kidney Injury (AKI) following interventional coronary angiograms in patients with Chronic Kidney Disease (CKD).

Read more

https://ospreymed.com/wp-content/uploads/2020/09/DyeVert_Logo-4C.jpg 700 700 Cat Gilfillen https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Cat Gilfillen2020-07-30 20:40:492020-09-30 20:42:01GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)

US Government to Transform Kidney Care

July 12, 2019/in News

Osprey Medical (ASX: OSP) today announces its response to the US President signing an Executive Order aimed at transforming kidney care for more than 37 million Americans with some form of kidney disease. The initiative seeks to prevent kidney failure through better diagnosis, treatment and preventative care.

Read more

https://ospreymed.com/wp-content/uploads/2019/08/white-house.png 610 610 Cat Gilfillen https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Cat Gilfillen2019-07-12 20:50:082019-08-09 01:33:11US Government to Transform Kidney Care
Premier Inc.

AKI Burden of Illness Data Presented at Premier® Breakthroughs Conference

June 21, 2019/in News

Osprey Medical (ASX: OSP) today announces that Dr Anand Prasad, M.D., Director of the Cardiac Catheterization Laboratory at University Health System and Associate Professor of Medicine at UT Health Science Centre at San Antonio, Texas presented the Acute Kidney Injury (AKI) Burden of Illness Study1 at the Premier Breakthroughs 2019 Conference and Exhibition in Nashville, Tennessee on behalf of the study investigators.

Read more

https://ospreymed.com/wp-content/uploads/2018/12/premier-logo.jpg 610 610 Cat Gilfillen https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Cat Gilfillen2019-06-21 20:46:462019-08-09 01:35:22AKI Burden of Illness Data Presented at Premier® Breakthroughs Conference
Premier Inc.

Osprey Medical, Inc. Awarded Premier Purchasing Agreement for DyeVert™ PLUS Contrast Reduction System

December 11, 2018/in News

As part of Premier’s Technology Breakthroughs Program, Osprey Medical, Inc. has been awarded a group purchasing agreement giving Premier’s ~4,000 U.S. hospitals access to purchase the DyeVert Plus Contrast Reduction System. Osprey Medical’s DyeVert Plus System is the only technology cleared by the U. S. Food & Drug Administration for contrast reduction and real-time monitoring of dye dose delivered to patients during a coronary or peripheral angiogram. Use of the DyeVert Plus System has resulted in a mean 40% contrast media (dye) volume reduction, which has been shown to be statistically significant and clinically meaningful.

Read more

https://ospreymed.com/wp-content/uploads/2018/12/premier-logo.jpg 610 610 Cat Gilfillen https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Cat Gilfillen2018-12-11 20:47:232018-12-11 21:03:21Osprey Medical, Inc. Awarded Premier Purchasing Agreement for DyeVert™ PLUS Contrast Reduction System
Be Kind to Kidneys

Osprey Medical and GE Healthcare Launch New Educational Program to Increase Awareness of Strategies to Help Address Acute Kidney Injury (AKI)

September 20, 2018/in News

Osprey Medical (ASX:OSP) is pleased to announce a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys™ campaign. The campaign aims to increase awareness of strategies to help address acute kidney injury (AKI) following normal heart imaging procedures (angiograms) in patients with chronic kidney disease (CKD). As part of the campaign, Osprey Medical and GE Healthcare will sponsor a number of educational programs and seminars for healthcare professionals on how to address the risk of AKI.

Read more

https://ospreymed.com/wp-content/uploads/2017/07/Be-Kind-Kidneys-logo-home-1.png 806 1010 Rob Coleman https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Rob Coleman2018-09-20 23:36:462018-09-26 00:40:39Osprey Medical and GE Healthcare Launch New Educational Program to Increase Awareness of Strategies to Help Address Acute Kidney Injury (AKI)
DyeVert Plus

Cutting Down on Dye May Make Heart Procedures Safer for Kidney Patients

June 8, 2017/in News

San Antonio’s University Hospital is one of the first hospitals to use a device called DyeVert Plus. Bluetooth technology embedded in the syringe uses wireless transmission to track exactly how much dye is used for each image. Tests of the new device show it can reduce the amount of dye used in heart procedures on kidney patients by as much as 40 percent.

Read more
https://ospreymed.com/wp-content/uploads/2017/06/tpr-dyevert.jpg 600 800 Rob Coleman https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Rob Coleman2017-06-08 12:00:402020-03-10 23:59:19Cutting Down on Dye May Make Heart Procedures Safer for Kidney Patients
DyeVert™ PLUS System

Osprey Medical Receives US FDA Clearance for DyeVert™ Plus

March 9, 2017/in News

Osprey Medical today announced that it has received US FDA 510(k) clearance for its advanced DyeVert™ PLUS Contrast Reduction System. This new platform augments Osprey’s current technology with the capability to actively manage dye administration during coronary interventions.

DyeVert PLUS received European CE Mark in 4Q 2016. The company further validated its dye savings capabilities through initial market testing with multiple physicians in Germany and Italy, which showed a 44% contrast reduction. The product received strong positive feedback on the utility of real-time contrast monitoring and ease-of-use.

Read more

https://ospreymed.com/wp-content/uploads/2017/04/DyeVert-PLUS-System.jpg 733 813 Rob Coleman https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Rob Coleman2017-03-09 01:40:312017-07-05 20:13:10Osprey Medical Receives US FDA Clearance for DyeVert™ Plus
DyeVert™ PLUS System

Osprey Introduces DyeVert PLUS at TCT

November 2, 2016/in News

Osprey Medical is pleased to announce the expansion of its portfolio with introduction of the DyeVert™ PLUS Contrast Modulation/Monitoring System. This new platform integrates the current DyeVert technology with substantial patient management and monitoring capabilities. The system has received European CE Mark and FDA clearance is pending. The Company anticipates US availability Q1 2017.

Highlighted at the Transcatheter Cardiovascular Therapeutics (“TCT”) Conference, held October 29 – November 2 in Washington DC, the DyeVert PLUS received publicity via both podium presence and considerable booth exposure. As one of the world’s largest gatherings of heart specialists, TCT hosts over 6,000 medical professionals in the fields of interventional cardiology and vascular medicine.

Read more

https://ospreymed.com/wp-content/uploads/2017/04/DyeVert-PLUS-System.jpg 733 813 Rob Coleman https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Rob Coleman2016-11-02 01:17:002017-05-06 19:02:12Osprey Introduces DyeVert PLUS at TCT
DyeVert™ PLUS System

Osprey to present at TCT 2016

October 26, 2016/in News

Osprey Medical is pleased to announce the Company’s scheduled presentations for the upcoming Transcatheter Cardiovascular Therapeutics (“TCT”) Conference, which is being held October 29 to November 2 in Washington, DC.

The TC is a leading international cardiovascular conference and one of the world’s largest gathering of heart specialists. The meeting hosts around 11,000 attendees with over 6,000 international medical professionals in the fields of interventional cardiology and vascular medicine.

Read more

https://ospreymed.com/wp-content/uploads/2017/04/DyeVert-PLUS-System.jpg 733 813 Rob Coleman https://ospreymed.com/wp-content/uploads/2021/03/osprey-logo-448w.png Rob Coleman2016-10-26 01:51:552017-07-05 20:17:04Osprey to present at TCT 2016
Page 1 of 212

Osprey Medical Events

NCDR 2019 Annual Conference
March 13-15, 2019
New Orleans, LA

ACC.19
March 16-18, 2019
New Orleans, LA

SCAI Conference
May 19-22, 2019
Las Vegas, NV

TCT 2019
September 25-29, 2019
San Francisco, CA

Recent Posts

  • Osprey receives Supplier Horizon Award from Premier Inc
  • GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury (AKI)
  • US Government to Transform Kidney Care
  • AKI Burden of Illness Data Presented at Premier® Breakthroughs Conference
  • Osprey Medical, Inc. Awarded Premier Purchasing Agreement for DyeVert™ PLUS Contrast Reduction System

Archives

  • September 2020
  • July 2020
  • July 2019
  • June 2019
  • December 2018
  • September 2018
  • June 2017
  • March 2017
  • November 2016
  • October 2016
  • May 2016

© 2022 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered trademarks of Osprey Medical, Inc. in the United States and other countries.

Osprey YouTubeOsprey TwitterOsprey Facebook

Contact     Resources     Privacy     Terms of Use

Contact     Resources     Privacy     Terms of Use

Scroll to top

Analyst Coverage Disclaimer Please note that any opinions, esimates or forecasts regarding Osprey Medical's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Osprey Medical or its management. Osprey Medical does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Osprey Medical cannot guarantee its accuracy.

Check if you have read and acknowledged.